"Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self

Journal of Clinical Investigation

Volumn 116, Issue 5, 2006, Pages 1254-1263

  Merkler, Doron ^a   Horvath, Edit ^b   Bruck, Wolfgang ^a   Zinkernagel, Rolf M ^b   De La Torre, Juan Carlos ^c   Pinschewer, Daniel D ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN TISSUE; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MORPHOMETRICS; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RASMUSSEN SYNDROME; VIRUS INFECTION;

ANIMALS; AUTOIMMUNE DISEASES; BRAIN; CENTRAL NERVOUS SYSTEM; HUMANS; INFECTION; INFLAMMATION; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; T-LYMPHOCYTES, CYTOTOXIC; VIRUS DISEASES;

EID: 33646432257     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI27372     Document Type: Article

References (44)

1. Marie, P. 1884. Sclerose en plaque et maladie infecteuses. Prog. Med. 12:287-289.
2. Kurtzke, J.F. 1993. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6:382-427.
3. Ebers, G.C., et al. 1986. A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315:1638-1642.
4. Dyment, D.A., Ebers, G.C., and Sadovnick, A.D. 2004. Genetics of multiple sclerosis. Lancet Neurol. 3:104-110.
5. Sibley, W.A., Bamford, C.R., and Clark, K. 1985. Clinical viral infections and multiple sclerosis. Lancet. 1:1313-1315.
6. Alvarez-Lafuente, R., De las Heras, V., Bartolome, M., Picazo, J.J., and Arroyo, R. 2004. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch. Neurol. 61:1523-1527.
7. Kaprio, J., et al. 1992. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 35:1060-1067.
8. Menser, M.A., Forrest, J.M., and Bransby, R.D. 1978. Rubella infection and diabetes mellitus. Lancet. 1:57-60.
9. Gamble, D.R., Kinsley, M.L., FitzGerald, M.G., Bolton, R., and Taylor, K.W. 1969. Viral antibodies in diabetes mellitus. Br. Med. J. 3:627-630.
10. Hyoty, H., et al. 1995. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes. 44:652-657.
11. Yoon, J.W., Austin, M., Onodera, T., and Notkins, A.L. 1979. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300:1173-1179.
12. Rothwell, P.M., Staines, A., Smail, P., Wadsworth, E., and McKinney, P. 1996. Seasonality of birth of patients with childhood diabetes in Britain. BMJ. 312:1456-1457.
13. Dahlquist, G.G., Ivarsson, S., Lindberg, B., and Forsgren, M. 1995. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes. 44:408-413.
14. Todd, J.A., Bell, J.I., and McDevitt, H.O. 1987. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 329:599-604.
15. Gamble, D.R., and Taylor, K.W. 1969. Seasonal incidence of diabetes mellitus. Br. Med. J. 3:631-633.
16. Kulmala, P., et al. 1998. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J. Clin. Invest. 101:327-336.
17. Rasmussen, T., Olszewski, J., and Lloydsmith, D. 1958. Focal seizures due to chronic localized encephalitis. Neurology. 8:435-445.
18. Bien, C.G., et al. 2002. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann. Neurol. 51:311-318.
19. Hart, Y. 2004. Rasmussen's encephalitis. Epileptic Disord. 6:133-144.
20. Fujinami, R.S., and Oldstone, M.B. 1985. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 230:1043-1045.
21. Miller, S.D., et al. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133-1136.
22. Horwitz, M.S., et al. 1998. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4:781-785.
23. von Herrath, M.G., Fujinami, R.S., and Whitton, J.L. 2003. Microorganisms and autoimmunity: making the barren field fertile? Nat. Rev. Microbiol. 1:151-157.
24. Homann, D., et al. 2002. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity. 16:403-415.
25. Benoist, C., and Mathis, D. 2001. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2:797-801.
26. Anderson, M.S., et al. 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science. 298:1395-1401.
27. Traub, E. 1936. The epidemiology of lymphocytic choriomeningitis in white mice. J. Exp. Med. 64:183-200.
28. Billingham, R.E., Brent, L., and Medawar, P.B. 1953. "Actively acquired tolerance" of foreign cells. Nature. 172:603-606.
29. Gossmann, J., Lohler, J., and Lehmann-Grube, F. 1991. Entry of antivirally active T lymphocytes into the thymus of virus-infected mice. J. Immunol. 146:293-297.
30. Pinschewer, D.D., Perez, M., Sanchez, A.B., and de la Torre, J.C. 2003. Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 100:7895-7900.
31. Pinschewer, D.D., et al. 2004. Kinetics of protective antibodies are determined by the viral surface antigen. J. Clin. Invest. 114:988-993. doi:10.1172/JCI200422374.
32. Cole, G.A., Nathanson, N., and Prendergast, R.A. 1972. Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature. 238:335-337.
33. Luzuriaga, K., et al. 2000. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. J. Virol. 74:6984-6991.
34. Grob, P., et al. 1999. Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection. J. Virol. 73:4748-4754.
35. Aichele, P., et al. 1994. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. U. S. A. 91:444-448.
36. Probst, H.C., et al. 2003. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171:5415-5422.
37. Oldstone, M.B., Dales, S., Tishon, A., Lewicki, H., and Martin, L. 2005. A role for dual viral hits in causation of subacute sclerosing panencephalitis. J. Exp. Med. 202:1185-1190.
38. Cairns, H.J.F. 1950. Intracerebral inoculation of mice: fate of the inoculum. Nature. 166:910-911.
39. Ohashi, P.S., et al. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:305-317.
40. Vreugdenhil, G.R., et al. 1998. Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia. 41:40-46.
41. Walker, L.S., and Abbas, A.K. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2:11-19.
42. Ridge, J.P., Fuchs, E.J., and Matzinger, P. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science. 271:1723-1726.
43. Opsahl, M.L., and Kennedy, P.G. 2005. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain. 128:516-527.
44. Ostler, T., et al. 2001. An improved protocol for measuring cytotoxic T cell activity in anatomic compartments with low cell numbers. J. Immunol. Methods. 257:155-161.